Body Vision Medical has announced exclusive distribution agreements to expand the reach of its LungVision artificial intelligence (AI)-driven imaging system in Central and South America.

The partnerships with DeLeC Científica Uruguaya and Bio Scan aim to enhance access to the LungVision technology in Bolivia, Argentina, Paraguay, Uruguay and Mexico.

LungVision leverages AI to convert X-ray images into real-time, intraoperative CT scans, revolutionising the way bronchoscopists visualise and biopsy pulmonary lesions, and integrates into their existing medical workflows.

It is designed to enhance the precision of lung nodule biopsies, potentially leading to earlier-stage cancer detection, and improves patient survival rates.

Body Vision Medical Sales and Marketing Development vice-president Jon Ulvestad said: “As lung cancer screening guidelines evolve to encompass earlier and more inclusive lung cancer screening of high-risk individuals, the capacity of institutions and clinicians to perform diagnostic bronchoscopy is going to have to grow commensurately to handle the incremental volume.

“These new partnerships with Bio Scan and DeLeC are important strides toward making a solution like LungVision that can economically increase both lung nodule biopsy capacity and diagnostic accuracy available to markets that can really benefit from such a technology.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The agreements mark a significant step in Body Vision Medical’s strategy to make LungVision available in 60 markets by 2025. With these new partnerships, the company’s distribution network now spans 36 countries globally.

In August this year, the company signed distribution agreements with Kral Medical Solutions, Paragon Care and Prism Technologies for the LungVision system.

The partnerships enabled the company to launch the system in Australia and New Zealand, Hong Kong, Macao, Romania and the entire Greater Bay Area.